GUVVALI, D. and MOHANTY, D. 2026. A QUALITY BY DESIGN DRIVEN DEVELOPMENT AND CHARACTERIZATION OF PALBOCICLIB-LOADED MESOPOROUS SILICA NANOPARTICLES IN HEPATOCELLULAR CARCINOMA THERAPY: ASSESSMENT OF CYTOTOXIC AND APOPTOTIC EFFECTS ON HEPG2 CELL LINE. International Journal of Applied Pharmaceutics. 18, 3 (Apr. 2026). DOI:https://doi.org/10.22159/ijap.2026v18i3.57785.